Hanmi Pharm Co Ltd (128940) - Total Liabilities

Latest as of September 2025: ₩694.79 Billion KRW ≈ $470.85 Million USD

Based on the latest financial reports, Hanmi Pharm Co Ltd (128940) has total liabilities worth ₩694.79 Billion KRW (≈ $470.85 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Hanmi Pharm Co Ltd (128940) cash flow conversion to assess how effectively this company generates cash.

Hanmi Pharm Co Ltd - Total Liabilities Trend (2010–2024)

This chart illustrates how Hanmi Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Hanmi Pharm Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Hanmi Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hanmi Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Blue Star Limited NSE:BLUESTARCO	India	Rs47.71 Billion
Harvey Norman Holdings Ltd AU:HVN	Australia	AU$3.82 Billion
Iljin Electric Co KO:103590	Korea	₩800.47 Billion
Cosan SA ADR NYSE:CSAN	USA	$93.69 Billion
Shake Shack Inc NYSE:SHAK	USA	$1.34 Billion
Caesars Entertainment Corporation NASDAQ:CZR	USA	$27.93 Billion
H&R Block Inc NYSE:HRB	USA	$3.17 Billion
Asbury Automotive Group Inc NYSE:ABG	USA	$7.13 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down Hanmi Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 128940 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.59	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.34	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hanmi Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hanmi Pharm Co Ltd (2010–2024)

The table below shows the annual total liabilities of Hanmi Pharm Co Ltd from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩780.09 Billion ≈ $528.66 Million	-2.30%
2023-12-31	₩798.46 Billion ≈ $541.10 Million	-12.77%
2022-12-31	₩915.36 Billion ≈ $620.33 Million	-9.23%
2021-12-31	₩1.01 Trillion ≈ $683.43 Million	-3.97%
2020-12-31	₩1.05 Trillion ≈ $711.66 Million	-3.78%
2019-12-31	₩1.09 Trillion ≈ $739.66 Million	+21.01%
2018-12-31	₩901.95 Billion ≈ $611.24 Million	+3.85%
2017-12-31	₩868.51 Billion ≈ $588.58 Million	+0.70%
2016-12-31	₩862.45 Billion ≈ $584.47 Million	-11.80%
2015-12-31	₩977.78 Billion ≈ $662.63 Million	+120.18%
2014-12-31	₩444.09 Billion ≈ $300.95 Million	+6.25%
2013-12-31	₩417.95 Billion ≈ $283.24 Million	-1.95%
2012-12-31	₩426.25 Billion ≈ $288.86 Million	+4.08%
2011-12-31	₩409.53 Billion ≈ $277.53 Million	-3.03%
2010-12-31	₩422.34 Billion ≈ $286.22 Million	--

About Hanmi Pharm Co Ltd

KO:128940 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$3.95 Billion

₩5.83 Trillion KRW

Market Cap Rank

#4184 Global

#110 in Korea

Share Price

₩460000.00

Change (1 day)

-4.76%

52-Week Range

₩257500.00 - ₩626000.00

All Time High

₩666173.23